Therapies
Friday, May 17th, 2013
Metapress: April 23, 2013 Abstract Central post-stroke pain syndrome (CPSP) is a debilitating sequel that can follow thalamic sensory stroke. Less well recognized, CPSP follows lateral medullary stroke and parietal cortical stroke and may develop anywhere along the spinothalamic or trigemino-thalamic pathways. Patients describe sharp, stabbing, or burning pain and experience hyperpathia and especially allodynia. […]
News
Friday, May 17th, 2013
CIRCOUTCOMES: May 14, 2013 Background—African Americans receive acute stroke treatment less often than non-Hispanic whites. Interventions to increase stroke preparedness (recognizing stroke warning signs and calling 911) may decrease the devastating effects of stroke by allowing more patients to be candidates for acute stroke therapy. In preparation for such an intervention, we used a community-based participatory […]
Guidelines, News
Friday, May 17th, 2013
Circulation: May 9, 2013 Cardiovascular disease (CVD) is the leading cause of death in the United States. Despite efforts promoting primary and secondary CVD prevention,2–8 obesity and physical inactivity remain at epidemic proportions, with >60% of Americans adults overweight or obese and >50% not performing recommended levels of physical activity.9 Similarly, hypertension, hypercho- lesterolemia, and other CVD risk […]
News
Friday, May 17th, 2013
STROKEAHA: May 9, 2013 Background and Purpose—Cerebrovascular and cardiovascular disease share common risk factors. Our goal was to determine whether levels of N-terminal brain natriuretic peptide (NT-proBNP) and cardiac troponin T measured with a highly sensitive assay (hs-cTnT) are associated with silent brain infarcts (BIs) and white matter lesions (WMLs) on MRI in the Atherosclerosis Risk […]
News
Friday, May 17th, 2013
Neurology: May 8, 2013 Objective: We compared manual infarct definition, which is time-consuming and open to bias, with an automated abnormal tissue detection method in measuring corticospinal tract–infarct overlap volumes in chronic stroke patients to help predict motor outcome. Methods: Using diffusion tensor imaging and probabilistic tractography, 4 corticospinal tracts from the primary motor cortex, dorsal and ventral […]
News
Friday, May 17th, 2013
Am. J. Epidemiology: May 3, 2013 Weight gain increases the prevalence of obesity, a risk factor for cardiovascular disease. Nevertheless, unintentional weight loss can be a harbinger of health problems. The Atherosclerosis Risk in Communities Study (1987–2009) included 15,792 US adults aged 45–64 years at baseline and was used to compare associations of long-term (30 years) […]
Atrial Fibrillation
Saturday, May 11th, 2013
JACC: May 1, 2013 Objective The aim of this study was to examine the effect of continuous positive airway pressure (CPAP) therapy on atrial fibrillation (AF) recurrence in patients with obstructive sleep apnea (OSA) undergoing pulmonary vein isolation (PVI). Background OSA is a predictor of AF recurrence following PVI. However the impact of CPAP therapy on PVI […]
Atrial Fibrillation
Saturday, May 11th, 2013
JMCP: May 1, 2013 BACKGROUND: Atrial fibrillation (AF) imposes a substantial clinical and
economic burden on the U.S. health care system. Despite national guidelines that recommend oral anticoagulation for stroke prevention, the literature consistently reports its underuse in AF patients with moderate to high stroke risk. OBJECTIVE: To assess the economic burden of underuse and […]
Atrial Fibrillation
Saturday, May 11th, 2013
EP Lab Digest: April 30, 2013 Atrial fibrillation can be a scary ailment. Out of nowhere, the heart can race, causing fatigue, dizziness, and a profound sense of loss of control. Afib patients don’t feel in charge of their own bodies. Then, doctors give them instructions with little or no explanation, making their scary condition […]
Clinical Trials
Saturday, May 11th, 2013
JACC: May 14, 2013 Objectives This study sought to investigate the outcomes following cardioversion or catheter ablation in patients with atrial fibrillation (AF) treated with warfarin or rivaroxaban. Background There are limited data on outcomes following cardioversion or catheter ablation in AF patients treated with factor Xa inhibitors. Methods We compared the incidence of electrical cardioversion (ECV), pharmacologic […]
